Simultaneous quantification of five Beta-lactam antibiotics in human plasma by HPLC-DAD: Clinical application for ceftazidime treatment in intensive care units
Frippiat, Frédéric ; Université de Liège - ULiège > Maladies infectieuses et médecine interne générale - Direction médicale
Charlier, Corinne ; Université de Liège - ULiège > Département de pharmacie > Chimie toxicologique
Language :
English
Title :
Simultaneous quantification of five Beta-lactam antibiotics in human plasma by HPLC-DAD: Clinical application for ceftazidime treatment in intensive care units
Gustafsson I, Lowdin E, Odenholt I, Cars O. Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model. Antimicrob Agents Chemother 2001; 45: 2436-40.
Craig W A. Pharmacokinetic/pharmacodynamic parameters : rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1-10.
Mouton J W, Vinks A A. Is continuous infusion of beta-lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations. J Antimicrob Chemother 1996; 38: 5-15.
Mouton J W, den Hollander J G. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 1994; 38: 931-36.
Samanidou V F, Ioannou A S, Papadoyannis I N. The use of a monolithic column to improve the simultaneous determination of four cephalosporin antibiotics in pharmaceuticals and body fluids by HPLC after solid phase extraction - a comparison with a conventional reversed phase silica based column. J Chromatogr B 2004; 809: 175-82.
Ehrlich M, Daschner F D, Kümmener K. Rapid antibiotic drug monitoring: meropenem and ceftazidime determination in serum and bronchial secretions by high-performance liquid chromatography-integrated sample preparation. J Chromatogr B 2001; 751: 357-63.
Bafeltowska J J, Buszman E, Mandat K, Hawranek J. Determination of cefotaxime and desacetylcefotaxime in cerebrospinal fluid by solid-phase extraction and high-performance liquid chromatography. J Chromatogr A 2002; 976: 249-54.
Ozkan Y, Kucukguzel I, Ozkan S A, Aboul-Enein HY. A rapid, sensitive high performance liquid chromatographic method for the determination of meropenem in pharmaceutical dosage form, human serum and urine. Biomed Chromatogr 2001; 15: 263-6.
Denooz R, Charlier C. Simultaneous determination of five β-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem, piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B 2008; 864: 161-67.
Sun H K, Kuti J L, Nicolau D P. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program. Crit Care Med 2005; 33: 2222-27.
Hughes W T, Armstrong D, Bodey G P et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-51.
Roberts J A, Webb A R, Lipman J. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients. Int J Antimicrob Ag 2007; 29: 117-28.
Van Dalen R, Vree T B, Baars A M, Termond E. Dosage adjustment for ceftazidime in patients with impaired renal function. Eur J Clin Pharmacol 1986; 30: 597-605.
Levey A S, Bosch J P, Lewis J B et al. A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
(http://www.eucast.org); European Committee on Antimicrobial Susceptibility Testing - EUCAST; December 2009.
Mouton J W, Vinks A A, Punt N C. Pharmacokinetic - pharmacodynamic modelling of activity of ceftazidime during continuous and intermittent infusion. Antimicrob Agents Chemother 1997; 41: 733-38.
Angus B J, Smith M D, Suputtamongkol Y et al. Pharmacokinetic -pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis. Br J Clin Pharmacol 2000; 50 : 184-91.
Hyatt J M, McKinnon P S, Zimmer G S, Schentag J J. The importance of pharmacokinetic-pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clin Pharmacokinet 1995; 28: 143-60.
MacGowan A P, Bowker K E. Continuous infusion of β-lactam antibiotics. Clin Pharmacokinet 1998; 35: 391-402.
Gomez C M, Cordingly J J, Palazzo M G. Altered pharmacokinetics of ceftazidime in critically ill patients. Antimicrob Agents Chemother 1999; 43: 1798-1802.